| Literature DB >> 18226032 |
Abstract
Implantable cardioverter-defibrillators (ICD) in adults have shown to be safe and effective for both primary and secondary prevention of sudden cardiac death (SCD). In children and patients with congenital heart disease prospective trials to evaluate the safety and efficacy of these devices are still lacking. This review will discuss the different aspects of ICD therapy in children with regard to current indications, effectiveness, problems related to size and growth, inappropriate shock therapy, and quality of life.Entities:
Mesh:
Year: 2008 PMID: 18226032 DOI: 10.1111/j.1540-8159.2008.00952.x
Source DB: PubMed Journal: Pacing Clin Electrophysiol ISSN: 0147-8389 Impact factor: 1.976